Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

U.S. Medical Foods Market Size, Share, and Trends Forecast, 2026-2033 | Market to Reach USD 10.7 Billion at 5.5% CAGR as Disease-Specific Nutrition Adoption Rises

globenewswire.com
ABT Abbott is mentioned for offering specific medical food products like Osmolite 1.2 and 1.5 Cal for patients needing fiber-free enteral nutrition, indicating their participation in the growing medical foods market.

U.S. Medical Foods Market Size, Share, and Trends Forecast, 2026-2033 | Market to Reach USD 10.7 Billion at 5.5% CAGR as Disease-Specific Nutrition Adoption Rises Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "U.S. Medical Foods Market Size, Share & Trends Analysis Report by Route Of Administration, Product, Application, Sales Channel, Module, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The U.S. medical foods market was valued at an estimated USD 6.9 billion in 2025 and is projected to reach USD 10.7 billion by 2033, expanding at a CAGR of 5.5% from 2026 to 2033. Market growth is supported by the rising geriatric population, the increasing prevalence of chronic and rare diseases, and wider adoption of disease-specific nutritional formulas across clinical care settings.

Chronic disease trends are strengthening demand for targeted nutritional interventions. Data published by the Centers for Disease Control and Prevention in April 2025 indicated that approximately 194 million U.S. adults, representing 76.4% of the adult population, reported at least one chronic condition. More than 51% had multiple chronic conditions. The burden is especially pronounced among older adults, with nearly 93% of people aged 65 and above affected by at least one chronic disease in 2023.

Neurological disorders are also contributing to U.S. medical foods market growth. Approximately 7.2 million Americans are currently living with Alzheimer's disease, and the affected population is expected to continue increasing. This expanding patient base is creating sustained demand for medical foods used as adjunct therapy within clinical treatment pathways for neurological, metabolic, gastrointestinal, and other health conditions.

The increasing incidence of cancer, gastrointestinal disorders, inherited metabolic diseases, and rare conditions is accelerating the use of specialized nutrition. Medical foods are being incorporated into patient management strategies to support nutritional requirements, improve treatment tolerance, and reduce the potential for drug-nutrient interactions. Gastrointestinal care frequently requires fiber-free or tolerance-focused formulas, while oncology nutrition often prioritizes high-protein, energy-dense products that address weight loss, oral discomfort, taste changes, mucositis, and other treatment-related complications.

Major market participants continue to expand disease-specific product portfolios. Abbott offers Osmolite 1.2 and 1.5 Cal for patients requiring fiber-free enteral nutrition. Danone's Milupa range supports the dietary management of inherited metabolic disorders under medical supervision. Nestle BOOST SOOTHE provides 300 kcal and 10 g of protein per serving for patients experiencing oral discomfort or treatment-related nutrition challenges, particularly during cancer care. These offerings reflect the industry's focus on formulation precision, patient tolerance, and condition-specific nutritional support.

Market Segmentation Covered in the Report

The report evaluates country-level revenue growth and industry trends from 2021 to 2033. The analysis segments the market by route of administration, product, application, module, and sales channel.

Continued innovation in targeted formulations, combined with the growing clinical emphasis on nutrition-based disease management, is expected to support long-term expansion of the U.S. medical foods market. Rising healthcare needs among aging adults and patients with complex chronic conditions will remain central to demand through 2033.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Market Definitions

1.3. Information Procurement

1.3.1. Purchased Database

1.3.2. Internal Database

1.3.3. Secondary Sources & Third-Party Perspectives

1.3.4. Primary Research

1.3.5. Details of Primary Research

1.4. Information Analysis

1.4.1. Data Analysis Models

1.5. Market Formulation & Data Visualization

1.5.1. Commodity Flow Analysis

1.5.1.1. Approach 1: Commodity flow approach

1.5.1.2. Approach 2: Country-wise market estimation using a bottom-up approach

1.6. Data Validation & Publishing

1.7. U.S. Market: CAGR Calculation

1.8. List of Secondary Sources

1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segmental Snapshot

2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

3.1. Market Lineage

3.1.1. Ancillary Market Analysis

3.2. U.S. Medical Foods Market - Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Growing prevalence of chronic diseases

3.2.1.2. Rising geriatric population

3.2.1.3. Shifting trend toward consumption of disease-specific formulas

3.2.1.4. Growing demand for neonatal and preterm enteral

3.2.2. Market Restraint Analysis

3.2.2.1. Limited reimbursement and insurance coverage

3.2.2.2. Regulatory ambiguity and lack of clear classification

3.2.3. Market Opportunity Analysis

3.2.4. Market Challenge Analysis

3.3. Pricing Analysis

3.4. Industry Analysis

3.4.1. User Perspective Analysis

3.4.2. Key End Users

3.5. Technology Outlook

3.5.1. Technology Timeline

3.6. Business Environmental Tools Analysis: U.S. Medical Foods Market

3.6.1. Porter's Five Forces Analysis

3.6.2. PESTLE Analysis

Chapter 4. U.S. Medical Foods Market: Route of Administration Estimates & Trend Analysis

4.1. U.S. Medical Foods Market, By Route of Administration: Key Takeaways

4.2. U.S. Medical Foods Market: Route of Administration Movement & Market Share Analysis, 2025 & 2033

4.3. Oral

4.3.1. U.S. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)

4.4. Enteral

4.4.1. U.S. Enteral Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Medical Foods Market: Product Estimates & Trend Analysis

5.1. U.S. Medical Foods Market, By Product: Key Takeaways

5.2. U.S. Medical Foods Market: Product Movement & Market Share Analysis, 2025 & 2033

5.3. Pills

5.3.1. U.S. Pills Market Estimates and Forecasts, 2021 - 2033 (USD Million)

5.4. Powder

5.4.1. U.S. Powder Market Estimates and Forecasts, 2021 - 2033 (USD Million)

5.5. Liquid

5.5.1. U.S. Liquid Market Estimates and Forecasts, 2021 - 2033 (USD Million)

5.6. Others

5.6.1. U.S. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Medical Foods Market: Application Estimates & Trend Analysis

6.1. U.S. Medical Foods Market, By Application: Key Takeaways

6.2. U.S. Medical Foods Market: Application Movement & Market Share Analysis, 2025 & 2033

6.3. Chronic Kidney Disease

6.3.1. U.S. Chronic Kidney Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.4. Minimal Hepatic Encephalopathy

6.4.1. U.S. Minimal Hepatic Encephalopathy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.5. Chemotherapy-Induced Diarrhea

6.5.1. U.S. Chemotherapy-Induced Diarrhea Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.6. Pathogen-Related Infections

6.6.1. U.S. Pathogen-Related Infections Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.7. Diabetic Neuropathy

6.7.1. U.S. Diabetic Neuropathy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.8. ADHD

6.8.1. U.S. ADHD Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.9. Depression

6.9.1. U.S. Depression Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.10. Alzheimer's Disease

6.10.1. U.S. Alzheimer's Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.11. Nutritional Deficiency

6.11.1. U.S. Nutritional Deficiency Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12. Orphan Diseases

6.12.1. U.S. Orphan Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.2. Tyrosinemia

6.12.2.1. U.S. Tyrosinemia Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.3. Eosinophilic Esophagitis

6.12.3.1. U.S. Eosinophilic Esophagitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.4. FPIES

6.12.4.1. U.S. FPIES Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.5. Phenylketonuria

6.12.5.1. U.S. Phenylketonuria Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.6. MSUD

6.12.6.1. U.S. MSUD Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.7. Homocystinuria

6.12.7.1. U.S. Homocystinuria Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.12.8. Others

6.12.8.1. U.S. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.13. Wound Healing

6.13.1. U.S. Wound Healing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.14. Chronic Diarrhea

6.14.1. U.S. Chronic Diarrhea Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.15. Constipation Relief

6.15.1. U.S. Constipation Relief Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.16. Protein Booster

6.16.1. U.S. Protein Booster Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.17. Dysphagia

6.17.1. U.S. Dysphagia Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.18. Pain Management

6.18.1. U.S. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.19. Parkinson's Disease

6.19.1. U.S. Parkinson's Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.20. Epilepsy

6.20.1. U.S. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.21. Other cancer-related treatments

6.21.1. U.S. Other Cancer related treatments Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.22. Severe Protein Allergy

6.22.1. U.S. Severe Protein Allergy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.23. Cancer

6.23.1. U.S. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.24. Cachexia

6.24.1. U.S. Cachexia Market Estimates and Forecasts, 2021 - 2033 (USD Million)

6.25. Other

6.25.1. U.S. Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Medical Foods Market: Module Estimates & Trend Analysis

7.1. U.S. Medical Foods Market, By Module: Key Takeaways

7.2. U.S. Medical Foods Market: Module Movement & Market Share Analysis, 2025 & 2033

7.3. Amino Acid Module

7.3.1. U.S. Amino Acid Module Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.4. Protein Module

7.4.1. U.S. Protein Module Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.5. Vitamin & Mineral Modules

7.5.1. U.S. Vitamin & Mineral Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.6. Fatty Acid-based Modules

7.6.1. U.S. Fatty Acid-based Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.7. Carbohydrate Modules

7.7.1. U.S. Carbohydrate Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.8. Fiber Modules

7.8.1. U.S. Fiber Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.9. Ketogenic Modules

7.9.1. U.S. Ketogenic Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.10. Peptide-based Modules

7.10.1. U.S. Peptide-based Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.11. Hypoallergenic Modules

7.11.1. U.S. Hypoallergenic Modules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

7.12. Others (Electrolyte Module, etc.)

7.12.1. U.S. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Medical Foods Market: Sales Channel Estimates & Trend Analysis

8.1. U.S. Medical Foods Market, By Sales Channel: Key Takeaways

8.2. U.S. Medical Foods Market: Sales Channel Movement & Market Share Analysis, 2025 & 2033

8.3. DTC Sales Channel

8.3.1. Online Sales

8.3.1.1. U.S. Online Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)

8.3.2. Retail Sales

8.3.2.1. U.S. Retail Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)

8.4. Institutional Sales

8.4.1. U.S. Institutional Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)

8.4.2. Hospitals

8.4.2.1. U.S. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

8.4.3. Others (Long-term Care Facilities, etc.)

8.4.3.1. U.S. Others (Long-term Care Facilities, etc.) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Market Share Analysis, 2025 (%)

9.2. Company Categorization

9.3. Company Profiles/Listing

9.3.1. Danone

9.3.1.1. Overview

9.3.1.2. Financial Performance

9.3.1.3. Product Benchmarking

9.3.1.4. Strategic Initiatives

9.3.2. Nestle

9.3.2.1. Overview

9.3.2.2. Financial Performance

9.3.2.3. Product Benchmarking

9.3.2.4. Strategic Initiatives

9.3.3. Abbott

9.3.3.1. Overview

9.3.3.2. Financial Performance

9.3.3.3. Product Benchmarking

9.3.3.4. Strategic Initiatives

9.3.4. Targeted Medical Pharma, Inc.

9.3.4.1. Overview

9.3.4.2. Financial Performance

9.3.4.3. Product Benchmarking

9.3.4.4. Strategic Initiatives

9.3.5. Fresenius Kabi AG

9.3.5.1. Overview

9.3.5.2. Financial Performance

9.3.5.3. Product Benchmarking

9.3.5.4. Strategic Initiatives

9.3.6. Primus Pharmaceuticals, Inc.

9.3.6.1. Overview

9.3.6.2. Financial Performance

9.3.6.3. Product Benchmarking

9.3.6.4. Strategic Initiatives

9.3.7. Mead Johnson & Company, LLC (Acquired by Reckitt Benckiser Group PLC)

9.3.7.1. Overview

9.3.7.2. Financial Performance

9.3.7.3. Product Benchmarking

9.3.7.4. Strategic Initiatives

9.3.8. Alfasigma USA, Inc.

9.3.8.1. Overview

9.3.8.2. Financial Performance

9.3.8.3. Product Benchmarking

9.3.8.4. Strategic Initiatives

List of Tables [7]

List of Figures [56]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/o4gw1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.